What You Should Know:
– Bluesight, a provider of Medication Intelligence™ solutions for healthcare organizations, has acquired Sectyr, a top-tier compliance and audit management platform. Financial details of the acquisition were not disclosed.
– The strategic acquisition expands Bluesight’s offerings to include robust 340B audit and compliance tools, addressing the growing needs of its customers in navigating the complexities of the 340B Drug Pricing Program.
Sectyr: Simplifying 340B Compliance
Sectyr is recognized for its industry-leading solutions designed to simplify and streamline regulatory compliance and auditing, specifically for the 340B program. This program enables eligible healthcare organizations to purchase outpatient medications at significantly reduced prices, stretching scarce resources and improving access to vital medications for underserved populations.
Enhancing Bluesight’s Portfolio
By integrating Sectyr’s technology, Bluesight strengthens its commitment to providing comprehensive solutions for medication management and compliance. Bluesight’s customers now have access to:
- Enhanced 340B Audit Readiness: Tools to proactively manage 340B compliance and prepare for audits with confidence.
- Improved Compliance Oversight: Streamlined processes for monitoring and managing 340B program requirements.
- Reduced Risk: Mitigation of compliance risks and potential financial penalties associated with 340B program violations.
